dr. mcdermott on targeting pd-1 and pd-l1 in kidney cancer
Published 10 years ago • 284 plays • Length 0:42Download video MP4
Download video MP3
Similar videos
-
1:25
dr. mcdermott discusses pd-l1 expression in kidney cancer
-
1:24
dr. mcdermott on the use of anti–pd-1 combinations in mrcc
-
0:51
dr. mcdermott on pd-l1 expression in non-clear cell renal cell cancer
-
1:27
dr. mcdermott on vegf/pd-1 inhibition in rcc
-
2:07
dr. mcdermott on tki/immunotherapy combinations in rcc
-
3:16
what is pd1 and pdl1 in kidney cancer?
-
0:48
dr. pal discusses the role of pd-l1 in metastatic rcc
-
1:51
dr. mcdermott on vegf plus pd-1 in renal cell carcinoma
-
2:16
optimal targeting in metastatic kidney cancer - dr. david mcdermott asco 2014
-
6:44
immune checkpoint inhibition in renal cell carcinoma
-
2:23
importance of pd-l1 expression in kidney cancer
-
7:13
role of pd-l1 testing in kidney cancer
-
5:18
pd-l1 expression as a biomarker in renal cell carcinoma
-
1:58
dr. mcdermott on single-agent pembrolizumab in advanced rcc
-
3:48
pd-1 inhibitor use in kidney and bladder cancers
-
4:34
pd-1 inhibition in renal cell carcinoma
-
1:42
dr. mcdermott on immotion150 trial in rcc
-
16:48
kidney cancer immunotherapy: pd-1 pathway clinical trials
-
1:54
pd-l1 and other biomarkers for renal cell carcinoma